Explore the latest advances in the diagnosis, monitoring and management of dry AMD and GA — and how earlier intervention may help preserve vision and improve patient outcomes.
Key topics include:
- Early diagnosis & multimodal imaging
- AI & risk assessment
- Disease monitoring & progression
- Emerging treatment strategies
- Real-world experience with complement inhibition
- Long-term patient adherence & care
Join Programme Chair Prof. Adnan Tufail and leading experts Prof. Sandrine Zweifel, Prof. Stela Vujosevic, Dr. Marion Munk, Dr. Lejla Vajzovic and Dr. Kristina Pfau for an engaging discussion on the evolving management of dry AMD and GA.
Lehar, VIECON, Vienna
Saturday, October 3, 2026
10:15–11:15 CEST
Don’t miss this opportunity to explore how advances in diagnosis, risk assessment and treatment are shaping the future of care for patients with dry AMD and GA.
View the full program and add the session to your calendar HERE!
